TY  - GEN
AU  - Nagy, Peter
AU  - Haege, Alexander
AU  - Coghill, David R
AU  - Caballero, Beatriz
AU  - Adeyi, Ben
AU  - Anderson, Colleen S
AU  - Sikirica, Vanja
AU  - Cardo-Jalon, Esther
PY  - 2016
DO  - 10.1007/s00787-015-0718-0
SN  - 1018-8827
UR  - http://hdl.handle.net/20.500.12105/20247
AB  - Attention-deficit/hyperactivity disorder (ADHD) is associated with functional impairments in multiple domains of patients' lives. A secondary objective of this randomized, active-controlled, head-to-head, double-blind, dose-optimized clinical trial...
LA  - eng
PB  - Springer
KW  - Atomoxetine
KW  - Attention-deficit/hyperactivity disorder
KW  - Functional impairment
KW  - Lisdexamfetamine dimesylate
KW  - Weiss Functional Impairment Rating Scale-Parent Report
KW  - Child
KW  - Central Nervous System Stimulants
KW  - Dose-Response Relationship, Drug
KW  - Humans
KW  - Adolescent
KW  - Attention Deficit Disorder with Hyperactivity
KW  - Attention
KW  - Double-Blind Method
KW  - Methylphenidate
KW  - Male
KW  - Female
KW  - Atomoxetine Hydrochloride
KW  - Lisdexamfetamine Dimesylate
KW  - Treatment Outcome
TI  - Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate
TY  - research article
ER  -